FRA-1 expression in hyperplastic and neoplastic thyroid diseases

Clinical Cancer Research

Volumn 6, Issue 11, 2000, Pages 4300-4307

  Chiappetta, Gennaro ^a   Tallini, Giovanni ^b   De Biasio, Maria Cristina ^a   Pentimalli, Francesca ^a   De Nigris, Filomena ^a   Losito, Simona ^a   Fedele, Monica ^c   Battista, Sabrina ^c   Verde, Pasquale ^d   Santoro, Massimo ^c   Fusco, Alfredo ^e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^e Univ degli Studi di Catanzaro   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; THYROID DISEASE; THYROID HYPERPLASIA;

BIOPSY, NEEDLE; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-FOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033748788     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nucleotide sequence of the genome of a murine sarcoma virus
2. Fra-1: A serum-inducible, cellular immediate-early gene that encodes a fos-related antigen
3. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity
4. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation
5. Isolation and characterization of fra-2, an additional member of the fos gene family
6. Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: Both Fos and Jun contact DNA directly
7. Nuclear proto-oncogenes fos and jun
8. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation
9. Difference in transcriptional regulatory function between c-Fos and Fra-2
10. Cellular transformation and malignancy induced by ras require c-jun
11. Analysis of AP-1 function in cellular transformation pathways
12. Mouse jun D negatively regulates fibroblast growth and antagonizes transformation by ras
13. c-fos is required for malignant progression of skin tumors
14. Neoplastic trasformation of rat thyroid cells requires the fra-1 gene induction and multiple regulatory changes of the AP-1 components: Role of the HMGI-C protein
15. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo
16. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron
17. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos
18. SRY protein enhances transcription of Fos-related antigen 1 promoter constructs
19. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms
20. Blockage of c-MYC protein synthesis in human thyroid carcinoma cell lines reduces their growth in soft agar
21. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkB p65 protein expression
22. Detection of measles virus RNA in paraffin-embedded tissue
23. Molecular Cloning: A Laboratory Manual
24. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype
25. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: Transcription factor AP-1 is comprised of multiple protein complexes
26. The WHO histological classification of thyroid tumors: A commentary on the second edition
27. Thymosin β-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro
28. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma